Lancet 398 , 262276 (2021)
Semaglutide is the active ingredient in injectable drugs like Ozempic and Wegovy, as well as oral tablets like Rybelsus
Excessive supplementation can cause nausea, vomiting, abdominal cramps, diarrhoea, fishy skin, muscle weakness in people with uremia and seizure disorders in people with seizure disordersand
Monitoring for Symptoms: Patients using semaglutide should be educated about the signs and symptoms of gallbladder issues and advised to report any new or worsening symptoms to their healthcare provider promptly
Ozempic Ozempic, a brand of semaglutide, is mainly for type 2 diabetes, while Wegovy is a higher-dose version for weight loss
If you take insulin or sulfonylureas, be aware that restarting Wegovy may increase the risk of hypoglycaemia